Quantcast
Ever Growing Number Of Women With Gestational Diabetes

Ever Growing Number Of Women With Gestational Diabetes Suggests Future Will Be Filled With Children With Early Diabetes

Sonia Caprio (Yale University), Diabetologia New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that children exposed to gestational diabetes in the wombs of their mothers are...

Latest Glucose tolerance test Stories

2014-04-23 23:09:58

Live webinar to focus on the development of a novel telemetry device for continuous monitoring of glucose in rodents. The broadcast takes place on Tuesday, May 13, 2014 at 11:00am EDT (16:00 UK BST/ GMT +1). Toronto, Canada (PRWEB) April 23, 2014 Glucose monitoring options for preclinical research have historically been limited when compared to the options available for human monitoring. As an example, Continuous Glucose Monitors (CGMs) have been prevalent in human medical applications...

2013-07-30 13:00:18

Glucose intolerance or insulin resistance do not appear to be associated with pathological features of Alzheimer disease (AD) or detection of the accumulation of the brain protein β-amyloid (Αβ), according to a report published by JAMA Neurology, a JAMA Network publication. Glucose intolerance and diabetes mellitus have been proposed as risk factors for the development of AD, but evidence of this has not been consistent, the study background notes....

2011-08-31 11:27:46

A simple finger prick test during routine eye examinations at high street opticians could help to identify millions of people with previously undiagnosed Type 2 diabetes, according to new research. The researchers suggest earlier diagnosis could set people on the road to better management of the disease, which is the leading cause of blindness in the working age population, and that this could ultimately result in cost-savings for the NHS. The Durham University study suggests that...

2011-06-24 16:17:00

PARIS, June 24, 2011 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today data from four studies of its once-daily GLP-1 receptor agonist Lyxumia® (lixisenatide) that is in Phase III clinical development, including data that demonstrates positive results in type 2 diabetes patients not at goal on oral therapies or with basal insulin. These data are being presented or published at the American Diabetes Association's 71st Scientific Sessions in San...

2011-05-02 19:13:52

More than two-thirds of high-risk patients missed if recommended hemoglobin A1C test used alone  A new study found that the recommended blood test may not be enough to catch type 2 diabetes in overweight children, missing more than two-thirds of children at high-risk for the condition. Researchers from Children's Mercy Hospital and Clinics found that performing two tests "“ both the recommended hemoglobin A1C test and an oral glucose tolerance test "“ could dramatically...

2011-05-02 07:45:00

KANSAS CITY, Mo., May 2, 2011 /PRNewswire/ -- A new study found that the recommended blood test may not be enough to catch type 2 diabetes in overweight children, missing more than two-thirds of children at high-risk for the condition. Researchers from Children's Mercy Hospital and Clinics found that performing two tests - both the recommended hemoglobin A1C test and an oral glucose tolerance test - could dramatically reduce the risk of delayed diagnosis in overweight children. The...

2010-12-20 16:34:00

MADISON, N.J., Dec. 20, 2010 /PRNewswire/ -- Nearly one third of pregnant women are not being screened by a simple laboratory test for gestational diabetes mellitus (gestational diabetes), according to a study of more than 900,000 American women published online today in Obstetrics and Gynecology. The study, conducted by scientists at Quest Diagnostics (NYSE: DGX), suggests that a large number of women are not being screened according to medical guidelines and may unknowingly put...

2010-12-13 06:30:00

WORCESTER, Mass., Dec. 13, 2010 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTC Bulletin Board: GNBT) announced today that the peer-reviewed scientific journal Diabetes, Obesity and Metabolism has published new positive data in respect of Generex Oral-lyn(TM), the Company's proprietary buccal insulin spray product. The paper, entitled Buccal spray insulin in subjects with impaired glucose tolerance: the prevoral study, appears in Volume 13, Issue 1 (January 2011)...

2010-09-20 04:58:00

STOCKHOLM, September 20, 2010 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY)(http://www.bms.com) and AstraZeneca (NYSE: AZN)(http://www.astrazeneca-us.com) today announced results from a randomized, double blind Phase 3 clinical study, which demonstrated that the addition of the investigational drug dapagliflozin to existing glimepiride (sulphonylurea) therapy produced significant reductions in glycosylated hemoglobin levels (HbA1c) in adult patients with type 2...

2010-02-02 08:00:00

JACKSONVILLE, Fla., Feb. 2 /PRNewswire-USNewswire/ -- The American Association of Clinical Endocrinologists (AACE) today has approved the use of A1c as an additional diagnostic criterion for type 2 diabetes. An A1c of 6.5 or greater is now considered an alternate criterion for the diagnosis of type 2 diabetes. (Logo: http://www.newscom.com/cgi-bin/prnh/20090324/DC88061LOGO-b ) The decision was announced in a position statement entitled "The AACE/ACE Statement on the Use of A1c for the...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related